Investigating how parasite-derived vesicles affect Babesia infections and vaccine development
Parasite-Derived Vesicles in Babesia virulence and Vaccine Development
This study is looking at how tiny bubbles made by the Babesia parasite help it infect people and how we might use this information to create better vaccines, all to help prevent and treat babesiosis, a serious illness spread by ticks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11101475 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of vesicles produced by the Babesia parasite in its ability to infect humans and how these vesicles can be used to develop effective vaccines. The study examines the communication mechanisms between Babesia and the host's immune system, particularly how these vesicles modulate immune responses. By exploring the biology and virulence of Babesia, the research aims to uncover new strategies for preventing and treating babesiosis, a serious tick-borne illness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of babesiosis, particularly those living in endemic areas or with a history of tick exposure.
Not a fit: Patients who are not at risk for babesiosis or those who have already been diagnosed and treated for the infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a vaccine that protects against babesiosis, potentially saving lives and reducing the burden of this disease.
How similar studies have performed: Other research has shown promise in using similar approaches to understand and combat tick-borne diseases, indicating that this line of investigation could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Ben Mamoun, Choukri — Yale University
- Study coordinator: Ben Mamoun, Choukri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.